Referentielijst
Ancoli-Israel S (2001)
Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. European Journal of Cancer Care 2001; 10: 245-255.
Anderson KO (2003)
Anderson KO, Getto CJ, Mendoza TR et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression and community-dwelling adults. Journal of Pain and Symptom Management 2003; 25: 307-318.
Broström A (2004)
Broström A, Strömberg A, Dahlström et al. Sleep difficulties, daytime sleepiness and health-related quality of life. Journal of Cardiovascular Nursing 2004; 19: 234-242.
Bruera E (1996)
Bruera E, Fainsinger RL, Schoeller T et al. Rapid discontinuation of hypnotics in terminal cancer patients: a prospective study. Annals of Oncology 1996; 7: 855-856.
Buscemi N (2006)
Buscemi N, Vandermeer B, Hooton N et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. British Medical Journal 2006; 332: 385-393.
Cannici J (1983)
Cannici J, Malcolm R, Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. Journal of Behavioral Therapy and Experimental Psychiatry 1983; 14: 251-256.
Commissie Farmaceutische Hulp van het College voor zorgverzekeringen (2007)
Commissie Farmaceutische Hulp van het College voor zorgverzekeringen. Farmacotherapeutisch kompas. Utrecht: Roto Smeets Utrecht, 2007. (zie http://www.fk.cvz.nl/)
Culpepper L (2006)
Culpepper L. Secondary insomnia in the primary care setting: review of diagnosis, treatment and management. Current Medical Research and Opinion 2006; 22: 1257-1268.
Davidson JR (2007)
Davidson JR, Feldman-Stewart D, Brennenstuhl S et al. How to provide insomnia interventions to people with cancer: insights from patients. Psycho-Oncology 2007; 16: 1028-1038.
Davidson JR (2002)
Davidson JR, MacLean AW, Brundage MD et al. Sleep disturbance in cancer patients. Social Science and Medicine 2002; 54: 1309-1321.
Davis MP (2007)
Davis MP. Does trazodone have a role in palliating symptoms? Supportive Care in Cancer 2007; 15: 221-224.
Engstrom CA (1999)
Engstrom CA, Strohl RA, Rose L et al. Sleep alterations in cancer patients. Cancer Nursing 1999; 22:143-148.
Fiorentino L (2007)
Fiorentino L, Ancoli-Israel S. Sleep dysfunction in patients with cancer. Current Treatment Options in Neurology 2007; 9: 337-346.
Fortner B (2002)
Fortner BV, Stepanski EJ, Wang S et al. Sleep and quality of life in breast cancer patients. Journal of Pain and Symptom Management 2002; 24: 471-480.
George CF (2000)
George CF. Perspectives on the management of insomnia in patients with chronic respiratory distress. Sleep 2000; 23 (Suppl 1) S31-S35.
George CF (2003)
George CF, Bayliff CD. Management of insomnia in patients with chronic obstructive pulmonary disease. Drugs 2003; 63: 379-387.
Graci G (2005)
Graci G. Pathogenesis and management of cancer-related insomnia. Journal of Supportive Oncology 2005; 3: 349-359.
Hajjar RR (2008)
Hajjar RR. Sleep disturbances in palliative care. Clinical Geriatric Medicine 2008; 24: 83-91.
Hirst A (2001)
Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database of Systematic Reviews 2001; 4: CD003346.
Hugel H (2004)
Hugel H, Ellershaw JE, Cook L et al. The prevalence, key causes and management of insomnia in palliative care patients. Journal of Pain and Symptom Management 2004; 27: 316-321.
Knuistingh Neven A (2005)
Knuistingh Neven A, Lucassen PL, Bonsema K et al. NHG-Standaard Slaapproblemen en slaapmiddelen. Huisarts en Wetenschap 2005; 48: 402-415.
Koopman C (2002)
Koopman C, Nouriani B, Erickson V et al. Sleep disturbances in women with metastatic breast cancer. Breast Journal 2002; 8: 362-370.
Kvale EA (2006)
Kvale EA, Shuster JL. Sleep disturbance in supportive care of cancer: a review. Journal of Palliative Medicine 2006; 9: 437-450.
Kwaliteitsinstituut voor de gezondheidszorg CBO (2004)
Kwaliteitsinstituut voor de gezondheidszorg CBO. Conceptrichtlijn Zorg bij een verstoord slaap-waakritme. Utrecht: Kwaliteitsinstituut voor de gezondheidszorg CBO, 2004.
Lemoine P (2007)
Lemoine P, Nir T, Laudon M et al. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. Journal of Sleep Research 2007; 16: 372-380.
Lis CG (2007)
Lis CG, Gupta D, Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Supportive Care in Cancer 2007; 16: 261-266.
Matsuo N (2007)
Matsuo N, Morita T. Efficacy, safety and cost effectiveness of intravenous midazolam and flunitrazapam for primary insomnia in terminally ill patients with cancer: a retrospective multicenter audit study. Journal of Palliative Medicine 2007; 10: 1054-1062.
Mercadante S (2004)
Mercadante S, Girelli D, Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Supportive Care in Cancer 2004; 12: 355-359.
Miaskowski C (1999)
Miaskowski C, Lee KA. Pain, fatigue and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. Journal of Pain and Symptom Management 1999; 17: 320-332.
Moore P (2002)
Moore P, Dimsdale JE. Opioids, sleep and cancer-related fatigue. Medical Hypotheses 2002; 58: 77-82.
Morin CM (1994)
Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. American Journal of Psychiatry 1994; 151: 1172-1180.
Murtagh DRR (1995)
Murtagh DR, Greenwood KM. Identifying effective psychological treatment for insomnia: a meta-analysis. Journal of Consultative Clinical Psychology 1995; 63: 79-89.
Mystakidou K (2007)
Mystakidou K, Parpa E, Tsilika E et al. The relationship of subjective sleep quality, pain and quality of life in advanced cancer patients. Sleep 2007; 30: 737-742.
Mystakidou K (2007)
Mystakidou K, Parpa E, Tsilika E et al. Sleep quality in advanced cancer patients. Journal of Psychosomatic Research 2007; 62: 527-533.
Nelson JE (2001)
Nelson JE, Meier DE, Oei EJ et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Critical Care Medicine 2001; 29: 277-282.
Owen DC (1999)
Owen DC, Parker KP, Macguire DB. Comparison of subjective sleep quality in patients with cancer and healthy subjects. Oncology Nursing Forum 1999; 26: 1649-1651.
Paltiel O (2004)
Paltiel O, Marzec-Boguslawska A, Soskolne V et al. Use of tranquilizers and sleeping pills among cancer patients is associated with a poorer quality of life. Quality of Life Research 2004; 13: 1699-1706.
Passik SD (2003)
Passik SD, Whitcomb LA, Kirsh KL et al. An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients. Journal of Pain and Symptom Management 2003; 25: 284-287.
Pinto AC (1999)
Pinto AC, Evangelista T, Carvalho de M et al. Respiratory disorders in ALS: sleep and exercise studies. Journal of Neurological Science 1999; 169: 61-68.
Puntillo K (1997)
Puntillo K, Casella V, Reid M. Opioid and benzodiazepine tolerance and dependence: application of theory to critical care practice. Heart Lung 1997; 26: 317-324.
Redeker NS (2000)
Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression and quality of life of cancer patients undergoing chemotherapy. Scholarly Inquiry for Nursing Practice 2000; 14: 275-290.
Redeker NS (2005)
Redeker NS, Hilkert R. Sleep and quality of life in stable heart failure. Journal of Cardiac Failure 2005; 11: 700-704.
Sanna P (2002)
Sanna P, Bruera E. Insomnia and sleep disturbances. European Journal of Palliative Care 2002; 9: 8-12.
Sandek K (1999)
Sandek K, Andersson T, Bratel T et al. Sleep quality, carbon dioxide responsiveness and hypoxaemic patterns in nocturnal hypoxaemia due to chronic obstructive pulmonary disease (COPD) without daytime hypoxaemia. Respiratory Medicine 1999; 93: 79-87.
Sateia MJ (2004)
Sateia MJ, Nowell PD. Insomnia. Lancet 2004; 364: 1959-1973.
Savard J (2004)
Savard J, Davidson JR, Ivers H et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. Journal of Pain and Symptom Management 2004; 27: 513-522.
Savard J (2001)
Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. Journal of Clinical Oncology 2001; 19: 895–908.
Sela RA (2005)
Sela RA, Watanabe S, Nekolaichuk CL. Sleep disturbances in palliative care cancer patients attending a pain and symptom control clinic. Palliative Supportive Care 2005; 3: 23-31.
Sheely L (1996)
Sheely LC. Sleep disturbances in hospitalized patients with cancer. Oncology Nursing Forum 1996; 23: 109-111.
Simeit R (2004)
Simeit R, Deck R, Conta-Marx B. Sleep management training for cancer patients with insomnia. Supportive Care in Cancer 2004; 12: 176-183.
Schweitzer PK (2000)
Schweitzer PK. Drugs that disturb sleep and wakefulness. Uit: Kryger MH, Roth T, Dement WC (red.) Principles and Practice of Sleep medicine.3rd ed. Philadelphia: WB Saunders Company, 2000: 441-61.
The International Classification of Sleep Disorders (1997)
The International Classification of Sleep Disorders. Rochester, MN: American Sleep Disorders Association, 1997.
Theobald DE (2004)
Theobald DE. Cancer pain, fatigue, distress and insomnia in cancer patients. Clinical Cornerstone 2004; 6 (Suppl 1D): S15-S21.
Volicer L (2001)
Volicer L, Harper DG, Manning BC et al. Sundowning and circadian rhythms in Alzheimer’s disease. American Journal of Psychiatry 2001; 158: 704-711.
Wade AG (2007)
Wade AG, Ford I, Crawford G et al. Efficacy of prolonged-release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Current Medical Research and Opinion 2007; 23: 2597-2605.
Zammit GK (1999)
Zammit GK, Weiner J, Damato N et al. Quality of life in people with insomnia. Sleep 1999; 22 (Suppl 2): S379-S385.